Goddard Glenn Insider Trades

Insider Trading History

Track insider trading activity for Goddard Glenn. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $921k 69,213 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 41,316 shares
$32.66
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $540k 40,585 shares
Last Trade
Jan 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$158k 5,365 shares
$29.46
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $611k 45,950 shares
Last Trade
Jan 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$93.4k 3,062 shares
$30.49
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $40.8k 3,064 shares
Last Trade
Jan 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$93.4k 3,062 shares
$30.49
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $570k 42,888 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 38,834 shares
$40.75
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $205k 15,404 shares
Last Trade
Jan 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$90.3k 2,427 shares
$37.21
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $81.5k 6,126 shares
Last Trade
Jan 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$107k 3,062 shares
$34.89
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $237k 17,831 shares
Last Trade
Jan 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$107k 3,062 shares
$34.89
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $196k 14,769 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.03M 25,440 shares
$79.85
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $247k 18,600 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.49M 18,600 shares
$79.85
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $122k 9,188 shares
Last Trade
Jan 01, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$362k 3,062 shares
$118.24
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $40.7k 3,062 shares
Last Trade
Jan 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$362k 3,062 shares
$118.24
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $27.3k 2,049 shares
Last Trade
Jan 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$114k 1,013 shares
$112.24
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Sep 07, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.14M 6,964 shares
$163.25
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $46.3k 3,482 shares
Last Trade
Sep 07, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.14M 6,964 shares
$163.25
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $166k 12,451 shares
Last Trade
Sep 07, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.14M 6,964 shares
$163.25
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $556k 41,817 shares
Last Trade
Aug 31, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.98M 24,800 shares
$160.53
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $330k 24,800 shares
Last Trade
Aug 31, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.98M 24,800 shares
$160.53
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Aug 31, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.97M 24,800 shares
$160.22
$13.30
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $69.2k 5,200 shares
Last Trade
Aug 30, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$801k 5,200 shares
$153.95
$13.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up